APTULLAHOĞLU, E. Et Al. 2024. RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia. Biomedicines , vol.12, no.7 .

APTULLAHOĞLU, E., Nakjang, S., Wallis, J. P., Marr, H., Marshall, S., Willmore, E., ... Lunec, J.(2024). RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia. Biomedicines , vol.12, no.7.

APTULLAHOĞLU, ERHAN Et Al. "RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia," Biomedicines , vol.12, no.7, 2024

APTULLAHOĞLU, ERHAN Et Al. "RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia." Biomedicines , vol.12, no.7, 2024

APTULLAHOĞLU, E. Et Al. (2024) . "RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia." Biomedicines , vol.12, no.7.

@article{article, author={ERHAN APTULLAHOĞLU Et Al. }, title={RNA Sequencing Reveals Candidate Genes and Pathways Associated with Resistance to MDM2 Antagonist Idasanutlin in TP53 Wild-Type Chronic Lymphocytic Leukemia}, journal={Biomedicines}, year=2024}